Free Trial
OTCMKTS:PHMMF

Pharma Mar (PHMMF) Stock Price, News & Analysis

Pharma Mar logo
$96.20 0.00 (0.00%)
As of 05/27/2025

About Pharma Mar Stock (OTCMKTS:PHMMF)

Key Stats

Today's Range
$96.20
$96.20
50-Day Range
$80.91
$102.08
52-Week Range
$34.26
$105.60
Volume
74 shs
Average Volume
943 shs
Market Capitalization
$1.73 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.

Receive PHMMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma Mar and its competitors with MarketBeat's FREE daily newsletter.

PHMMF Stock News Headlines

Exploring High Growth Tech Stocks in Europe April 2025
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.
See More Headlines

PHMMF Stock Analysis - Frequently Asked Questions

Pharma Mar's stock was trading at $81.07 at the start of the year. Since then, PHMMF shares have increased by 18.7% and is now trading at $96.20.
View the best growth stocks for 2025 here
.

Shares of PHMMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/28/2025
Next Earnings (Estimated)
7/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:PHMMF
Previous Symbol
NASDAQ:PHMMF
CIK
N/A
Employees
509
Year Founded
1986

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$171.15 million
Cash Flow
$0.42 per share
Price / Cash Flow
231.27
Book Value
$11.62 per share
Price / Book
8.28

Miscellaneous

Free Float
N/A
Market Cap
$1.73 billion
Optionable
Not Optionable
Beta
0.25

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:PHMMF) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners